tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Promising Developments in Rocket Pharmaceuticals’ KRESLADI Gene Therapy Boost Buy Rating
RatingsPromising Developments in Rocket Pharmaceuticals’ KRESLADI Gene Therapy Boost Buy Rating
5d ago
RCKT
Promising Future for Rocket Pharmaceuticals: Buy Rating Affirmed on Kresladi’s Progress and Potential
PremiumRatings
Promising Future for Rocket Pharmaceuticals: Buy Rating Affirmed on Kresladi’s Progress and Potential
5d ago
RCKT
Promising Future for Rocket Pharmaceuticals: Buy Rating Backed by FDA Progress and Clinical Success
PremiumRatings
Promising Future for Rocket Pharmaceuticals: Buy Rating Backed by FDA Progress and Clinical Success
5d ago
RCKT
Cautious Hold Rating on Rocket Pharmaceuticals Amid Kresladi Developments and Danon Disease Uncertainty
PremiumRatings
Cautious Hold Rating on Rocket Pharmaceuticals Amid Kresladi Developments and Danon Disease Uncertainty
5d ago
RCKT
Rocket Pharmaceuticals’ FDA Resubmission for KRESLADI™ Accepted
PremiumCompany Announcements
Rocket Pharmaceuticals’ FDA Resubmission for KRESLADI™ Accepted
5d ago
8K
RCKT
Rocket Pharmaceuticals announces FDA acceptance of Kresladi BLA resubmission
PremiumThe FlyRocket Pharmaceuticals announces FDA acceptance of Kresladi BLA resubmission
5d ago
RCKT
Strategic Shift Towards Cardiovascular Platform Positions Rocket Pharmaceuticals for Future Growth
Premium
Ratings
Strategic Shift Towards Cardiovascular Platform Positions Rocket Pharmaceuticals for Future Growth
13d ago
RCKT
Rocket Pharmaceuticals Board Member Resigns in September
Premium
Company Announcements
Rocket Pharmaceuticals Board Member Resigns in September
16d ago
8K
RCKT
No jobs report amid shutdown, Apple pulls ICEBlock from App Store: Morning Buzz
PremiumThe Fly
No jobs report amid shutdown, Apple pulls ICEBlock from App Store: Morning Buzz
16d ago
Z
BA
Rocket Pharmaceuticals price target lowered to $7 from $9 at Leerink
PremiumThe Fly
Rocket Pharmaceuticals price target lowered to $7 from $9 at Leerink
16d ago
RCKT
Hold Rating on Rocket Pharmaceuticals Amid Strategic Shifts and Regulatory Challenges
PremiumRatings
Hold Rating on Rocket Pharmaceuticals Amid Strategic Shifts and Regulatory Challenges
16d ago
RCKT
Rocket Pharmaceuticals withdraws BLA for Fanskya
PremiumThe Fly
Rocket Pharmaceuticals withdraws BLA for Fanskya
16d ago
RCKT
Rocket Pharmaceuticals Withdraws FDA Application for Gene Therapy
PremiumCompany AnnouncementsRocket Pharmaceuticals Withdraws FDA Application for Gene Therapy
16d ago
8K
RCKT
Rocket Pharmaceuticals Announces Dr. Patel’s Departure Agreement
Premium
Company Announcements
Rocket Pharmaceuticals Announces Dr. Patel’s Departure Agreement
1M ago
8K
RCKT
Rocket Pharmaceuticals director buys $34.1K in common stock
Premium
The Fly
Rocket Pharmaceuticals director buys $34.1K in common stock
2M ago
RCKT
Promising Outlook for Rocket Pharmaceuticals: Buy Rating Affirmed Amidst Advancements in RP-A501 Study
PremiumRatings
Promising Outlook for Rocket Pharmaceuticals: Buy Rating Affirmed Amidst Advancements in RP-A501 Study
2M ago
RCKT
Rocket Pharmaceuticals CFO Aaron Ondrey resigns to pursue other opportunities
PremiumThe Fly
Rocket Pharmaceuticals CFO Aaron Ondrey resigns to pursue other opportunities
2M ago
RCKT
EMA says Rocket Pharmaceuticals withdraws MA application for Fanskya
PremiumThe Fly
EMA says Rocket Pharmaceuticals withdraws MA application for Fanskya
2M ago
RCKT
Hold Rating on Rocket Pharmaceuticals Amid Uncertainties in RP-A501 Study Resumption
PremiumRatings
Hold Rating on Rocket Pharmaceuticals Amid Uncertainties in RP-A501 Study Resumption
2M ago
RCKT
Cautious Optimism for Rocket Pharmaceuticals Amid Adjusted RP-A501 Trial Protocol
PremiumRatingsCautious Optimism for Rocket Pharmaceuticals Amid Adjusted RP-A501 Trial Protocol
2M ago
RCKT
Rocket Pharmaceuticals’ RP-A501 Study Advances with FDA Approval and Enhanced Safety Measures, Justifying Buy Rating
Premium
Ratings
Rocket Pharmaceuticals’ RP-A501 Study Advances with FDA Approval and Enhanced Safety Measures, Justifying Buy Rating
2M ago
RCKT
BofA upgrades Rocket Pharmaceuticals to Buy after clinical hold lifted
Premium
The Fly
BofA upgrades Rocket Pharmaceuticals to Buy after clinical hold lifted
2M ago
RCKT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >